Literature DB >> 32644164

European, Multicenter, Prospective, Non-comparative Clinical Evaluation of an Extended Depth of Focus Intraocular Lens.

Gerd U Auffarth, Ozana Moraru, Mihnea Munteanu, Daniele Tognetto, Paolo Bordin, Roberto Belucci, Ramin Khoramnia, Hyeck-Soo Son.   

Abstract

PURPOSE: To evaluate clinical and safety results obtained with an extended depth of focus (EDOF) intraocular lens (IOL).
METHODS: In this European, multicenter, prospective, uncontrolled, interventional study, 77 patients were enrolled in the study, 71 patients received bilateral implantation of the Mini Well Ready EDOF IOL (SIFI S.p.A.), and 68 patients completed the study and were evaluated 2 to 4 months postoperatively. Each clinical examination recorded uncorrected (UDVA) and corrected (CDVA) distance visual acuity, uncorrected (UIVA) and distance-corrected (DCIVA) intermediate visual acuity, and uncorrected (UNVA), distance-corrected (DCNVA), and corrected (CNVA) near visual acuity. A defocus curve from +2.00 to -5.00 diopters (D) was obtained, contrast sensitivity and reading ability were assessed, and the perception of dysphotopsia was evaluated.
RESULTS: Mean binocular visual results showed UDVA, UIVA, and UNVA values of -0.01 ± 0.15, 0.03 ± 0.10, and 0.10 ± 0.11 logMAR, respectively. Mean binocular defocus curve demonstrated a visual acuity of 0.30 logMAR or better from +2.00 to -3.00 D. Mean photopic contrast sensitivity values were 1.86, 2.18, 1,97, 1.51, and 1.17 at 1.5, 3.0, 6.0, 12.0, and 18.0 cycles per degree, respectively. A fluent reading speed of 80 words per minute was reached at 0.5 logRAD by 95.31% of patients without distance correction. The mean halo size was 33.06 ± 14.25, mean halo intensity was 38.00 ± 18.51, mean glare size was 23.85 ± 10.43, and mean glare intensity was 42.23 ± 13.22. One postoperative complication, a moderate photophobia, was observed and classified as related to the lens.
CONCLUSIONS: The Mini Well Ready EDOF IOL provides good visual acuity across various distances and functional reading ability provided at a near range, and delivers an enhanced contrast sensitivity while causing a low incidence of photic phenomena. [J Refract Surg. 2020;36(7):426-434.].
© 2020 Auffarth, Moraru, Munteanu, et al; licensee SLACK Incorporated.

Entities:  

Mesh:

Year:  2020        PMID: 32644164     DOI: 10.3928/1081597X-20200603-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  6 in total

1.  Clinical Performance of Extended Depth of Focus (EDOF) Intraocular Lenses - A Retrospective Comparative Study of Mini Well Ready and Symfony.

Authors:  Katarzyna Ewa Nowik; Kamil Nowik; Piotr Kanclerz; Jacek Paweł Szaflik
Journal:  Clin Ophthalmol       Date:  2022-05-26

2.  Clinical Outcomes with a Novel Extended Depth of Focus Presbyopia-Correcting Intraocular Lens: Pilot Study.

Authors:  María T Iradier; Verónica Cruz; Naty Gentile; Priscila Cedano; David P Piñero
Journal:  Clin Ophthalmol       Date:  2021-03-19

3.  Unilateral implantation of a new non-diffractive extended range-of-vision IOL in a young patient with Curschmann-Steinert myotonic dystrophy.

Authors:  Isabella Baur; Gerd U Auffarth; Grzegorz Łabuz; Ramin Khoramnia
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-17

4.  Laboratory analysis and ray visualization of diffractive optics with enhanced intermediate vision.

Authors:  Hyeck-Soo Son; Grzegorz Łabuz; Ramin Khoramnia; Timur M Yildirim; Gerd U Auffarth
Journal:  BMC Ophthalmol       Date:  2021-05-04       Impact factor: 2.209

5.  [Unilateral implantation of a new extended range of vision intraocular lens in a young patient].

Authors:  Isabella D Baur; Gerd U Auffarth; Grzegorz Łabuz; Christian S Mayer; Ramin Khoramnia
Journal:  Ophthalmologe       Date:  2020-12-10       Impact factor: 1.059

6.  Presbyopia correction after previous Intracor treatment: Combined implantation of a small-aperture and a non-diffractive extended-depth-of-focus lens.

Authors:  Isabella D Baur; Gerd U Auffarth; Grzegorz Łabuz; Christian S Mayer; Ramin Khoramnia
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.